Lipolysis of adipose tissue triglycerides releases glycerol. Twenty-four volunteers, of whom 6 were obese and 13 were women, received a primed-constant infusion of 2 H 5 -glycerol for 120 min during postabsorptive steadystate conditions. Arterial, abdominal venous, and interstitial (microdialysis) samples were taken, and a fourcompartment model was applied to assess subcutaneous abdominal adipose tissue glycerol kinetics. Adipose tissue blood flow was measured using 133 
T riglycerides in adipose tissue represent the body's major source of endogenous fuel and are mobilized when energy requirements exceed exogenous energy supply, such as during exercise (1) and fasting (2) . However, excessive body fat, particularly increased abdominal fat mass, is associated with increased rates of systemic lipolysis (3) and excessive release of free fatty acids into the circulation, contributing to insulin resistance, diabetes, and dyslipidemia (3, 4) . Therefore, dysregulation of lipolysis has important physiological and clinical implications.
The breakdown of endogenous fat involves the conversion of triglyceride to fatty acids and glycerol; complete hydrolysis of 1 mol triglyceride releases 3 mol fatty acids and 1 mol glycerol. Therefore, the rate of release of glycerol can be used to assess the lipolytic rate. Several methods have been used to measure glycerol kinetics in vivo in human subjects. Whole-body adipose tissue glycerol kinetics can be studied with intravenously infused isotopically labeled glycerol (5-7). However, interpretation of results from this technique is complicated by the contribution of glycerol derived from lipolysis of circulating triglyceride-rich lipoproteins (such as chylomicrons) by lipoprotein lipase (LPL). Regional abdominal adipose tissue glycerol kinetics can be studied by two methods that rely on arteriovenous balance principles (8) . One method involves placing a small catheter in a superficial abdominal vein to determine glycerol concentration in venous effluent from subcutaneous abdominal adipose tissue (7,9 -12) . The other more widely used approach places thin microdialysis tubes into subcutaneous adipose tissue, allowing the estimation of glycerol concentration in interstitial adipose tissue fluid (10 -19) . Correct interpretation of microdialysis results depends upon knowledge of the permeability of the capillary endothelium to glycerol diffusion, which is needed to convert interstitial glycerol concentrations to venous concentrations (15, 18, 19) . Changes in capillary permeability regulate glycerol release, but this issue has previously been little considered, perhaps in part because there has been no viable method of measuring it in vivo. Capillary permeability is determined by capillary diffusion capacity, which is measured as the product of permeability and surface area (ps) (20 -22) . Recently, Gudbjö rnsdó ttir et al. (22) published the first in vivo data for the ps for glucose and insulin in human muscle capillaries, using a combination of arteriovenous difference microdialysis and mathematical modeling methods.
The combined use of glycerol tracers, abdominal vein catheterization, and microdialysis probes, in conjunction with a mathematical modeling approach (23) , provides a novel potential approach for evaluating adipose tissue glycerol kinetics in vivo in human subjects and for esti-mating the ps for glycerol from in vivo data. This article reports the first application of this approach.
RESEARCH DESIGN AND METHODS
Twenty-four subjects participated in this study ( Table 1 ). All subjects were weight stable for at least 2 months before the study and were considered to be in good health after completing a comprehensive medical evaluation, including history and physical examination, blood tests, and electrocardiogram. Six subjects were obese (BMI Ͼ30 kg/m 2 ). In 15 subjects (12 female), body composition was measured by using dual-energy X-ray absorptiometry (Lunar Instruments, Madison, WI) within 2 weeks before the study. None of the subjects were taking regular medication, and premenstrual female subjects were studied during the follicular phase of their cycle. All obese subjects had normal glucose tolerance confirmed by a standard oral glucose tolerance test. The study was approved by the Human Studies Committee and the Clinical Research Center Scientific Advisory Board, and all subjects gave informed written consent. Other aspects of these studies have been previously reported (24) .
Subjects were admitted to the Clinical Research Center in the afternoon before the study. At 1800, subjects ingested a meal containing 12 kcal/kg body wt for lean subjects and 12 kcal/kg adjusted body wt for obese subjects (adjusted body weight ϭ ideal body weight [IBW] ϩ [actual body weight Ϫ IBW] ϫ 0.25). At 2000, subjects ingested a defined liquid formula snack containing 250 kcal, 40 g carbohydrate, 6.1 g fat, and 8.8 g protein (Ensure; Ross Laboratories, Columbus, OH). After this snack, all subjects fasted until completion of the study the following day.
The following morning, 20-gauge catheters were inserted into a forearm vein for isotope infusion and into a radial artery for arterial blood sampling. A superficial abdominal vein was cannulated with a 10-to 20-cm, 22-gauge polyurethane catheter (Hydrocath; Viggo-Spectramed, Oxnard, CA) (7, 9, 12, 24) . Blood obtained from this site represents effluent from adipose tissue and overlying skin. All vascular catheters were kept patent by continuous saline infusion.
Three or four microdialysis probes (CMA, Acton, MA) were placed percutaneously without anesthesia into subcutaneous abdominal adipose tissue. Each probe consisted of dialysis tubing (10 ϫ 0.5 mm, 20,000 MW cutoff) and was perfused overnight with Ringer's lactate solution (0.3 l/min) before insertion to ensure the elimination of any glycerol from the catheter itself. Perfusion of the probe permits the equilibration of adipose tissue interstitial glycerol with perfusate, which can be collected. All probes were placed within 10 cm of the midline and were at least 3 cm apart from each other. Each was continuously perfused with lactated Ringer's solution at a rate of 0.1 l/min by using a syringe infusion pump (Harvard Apparatus, South Natick, MA). Both venous and microdialysis catheters and the 133 Xe depot were positioned so as to sample the more superficial subcutaneous tissue as described by Enevoldsen et al. (25) .
Subjects remained supine throughout the study, and room temperature was kept constant at 23°C during the entire study. Baseline arterial and abdominal venous blood samples were obtained 60 min after catheters were placed. Adipose tissue interstitial fluid samples were collected 60 min after probe insertion. The first 60-min fraction of the dialysate effluent was discarded to eliminate the influence of the initial trauma caused by probe insertion on glycerol measurements. Previous studies (11, 12) Abdominal subcutaneous adipose tissue blood flow (ATBF) was evaluated using the 133 Xe washout technique (7, 11, 12, 19, 25) . Immediately after starting the isotope infusion, 120 -150 mCi of 133 Xe dissolved in 0.1 ml saline was injected over 60 s into the subcutaneous abdominal adipose tissue space. The decline in 133 Xe activity was monitored continuously from 60 to 120 min after injection with a sodium iodide scintillation detector (Canberra Industries, Meriden, CT) placed ϳ40 cm from the 133 Xe depot and coupled with a multichannel analyzer (ND 600; Schaumburg, IL) set to measure the 81 keV 133 Xe photopeak. Analyses. Arterial and venous plasma triglyceride concentrations were measured enzymatically (26) . Arterial and venous blood concentrations of glycerol were determined enzymatically with an automated analyzer (Technicon, Tarrytown, NY). Isotopic enrichment (tracer-to-tracee ratio [TTR]) of glycerol in plasma and in microdialysate fluid was determined by gas chromatography-mass spectrometry by using an MSD 5971 system (HewlettPackard, Palo Alto, CA) with a 12 m ϫ 0.2-mm HP-1 fused silica capillary column (Hewlett-Packard). Plasma was deproteinized with barium hydroxide and zinc sulfate and then cetrifuged to isolate the protein-free supernatant. The microdialysate samples and the supernatant of the plasma samples were passed through stacked cation (Dowex AG-50W-X8) and anion (Dowex AG-1-X8) exchange columns. A trimethylsilyl derivative of glycerol was formed and injected into the gas chromatography-mass spectrometer. Ions, produced by electron impact ionization, were selectively monitored at massto-charge ratios 205.1, 206.1, and 208.1.
Calculations. ATBF was calculated from
133 Xe clearance as previously described (7, 19, 26) , assuming an adipose tissue-to-blood partition coefficient for xenon of 10 ml/100 g for all subjects (17) (18) (19) 27) . Whole-body glycerol rate of appearance, R a(systemic) (mol ⅐ kg Ϫ1 ⅐ min Ϫ1 ), in blood was calculated by using Steele's equation for steady-state conditions modified for use with stable isotopes (28, 29) : R a(systemic) ϭ I/TTR art , where I is the isotope infusion rate in mol ⅐ kg Ϫ1 ⅐ min Ϫ1 and TTR art is the TTR of glycerol in arterial plasma at isotopic equilibrium.
Regional subcutaneous abdominal adipose tissue net glycerol release rate [R a(local) ], in ng ⅐ l00 g adipose tissue Ϫ1 ⅐ min Ϫ1 , was calculated by using standard principles of arteriovenous balance and blood glycerol concentrations (29) : R a(local) ϭ ATBF ϫ (Gly vein Ϫ Gly art ), where ATBF is the rate of subcutaneous ATBF in ml ⅐ 100 g adipose tissue Ϫ1 ⅐ min Ϫ1 and Gly art and Gly vein are arterial and venous blood glycerol concentrations in mol/l. R a(local) (mol ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 ) was also calculated by using standard arteriovenous balance methodology in conjunction with isotope tracer enrichment data (29) Our model is not able to determine the exact proportion of LPL-derived glycerol directed to the vein or adipose tissue interstitium. However, we can examine two boundary conditions: 1) when all LPL-derived glycerol enters the interstitium and none enters the vein directly (boundary condition P) and 2) when all LPL-derived glycerol enters the vein directly and none enters the interstitium (boundary condition Q). For any individual subject, the true value of each model parameter estimate lies between the two boundary conditions. Boundary condition P. By definition, F VL ϭ 0 and F IL ϭ F (LPL) . The relationship between arterial, abdominal venous, and interstitial glycerol is calculated as (20, 21) 
The fluxes F (out) , F VI , and F VA between compartments are indicated in Fig.  1 . TTR art , TTR vein , and TTR interstitial are glycerol TTR in arterial blood, venous blood, and interstitial fluid, respectively. This equation can be rearranged to
Boundary condition Q. By definition, F VL ϭ 0 and F IL ϭ F (LPL) . The relationships between arterial, abdominal venous, and interstitial glycerol are calculated as
F (out) is calculated as the product of glycerol concentration in the vein, and ATBF and F LPL are the product of plasma flow and the arteriovenous difference in triglyceride concentration. Summers et al. (12) considered that glycerol released by LPL would not enter the interstitium in significant amounts, i.e., boundary condition Q is physiologically more plausible.
For both boundary conditions, we used the parameters from our model in conjunction with single-pass unidirectional extraction (E) principles (21) to estimate the capillary diffusion capacity (ps), which is a measure of the capillary surface area and the permeability of the capillaries to glycerol. The single-pass unidirectional extraction, which is the amount of glycerol arriving in the arterial blood that is transported into the tissue, is estimated by the
However, E is also fundamentally related to capillary diffusion capacity
, where ps is the capillary diffusion capacity expressed in ml ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 . These equations can be combined to the following: ps ϭ ϪATBF 1og n (l Ϫ E).
Having calculated ps and E allows determination of interstitial glycerol concentration Gly interstitial , because
Gly interstitial ϭ Gly art ϩ (Gly vein Ϫ Gly art ϫ e (Ϫps/ATBF) ).
Data from previous studies allowed us to expect additional constraints on the model. First, the data from previous studies (7, 19) demonstrated no metabolism of labeled glycerol by adipose tissue. Therefore, the model does not need to include uptake of plasma-free glycerol into adipose tissue. Second, we assumed that the incorporation of labeled glycerol into triglyceride-rich lipoproteins was negligible during the short duration of the tracer infusion study. In similar studies, we found that isotopic enrichment of glycerol within triglyceride-rich lipoprotein was Ͻ3% plasma glycerol enrichment within this time of infusion (B.W.P., S.K., unpublished observations). Statistics. The glycerol concentration and enrichment data were normally distributed. To assess for steady-state conditions, we undertook an ANOVA of the plasma concentrations and enrichments, seeking an effect of time. Some model parameters were not normally distributed; therefore, nonparametric statistics were used when possible. Data are expressed as median (interquartile range), and Wilcoxon's and Spearman's (R s ) tests were used to analyze the data. A P value of Յ0.05 was considered to be statistically significant.
The model parameters for glycerol kinetics are expressed as the median of the parameters from the model run on the 24 subjects' observational data (i.e., median of the models), which is shown in Tables 2 and 3 . However, as an example of what individual data looked like, Figs. 2A and B show the parameter values obtained by entering the median observational data (concentrations and specific enrichments) from 24 subjects into the model (i.e., the model of the median data).
RESULTS
Glycerol concentrations and TTR. The measured glycerol TTR in artery, abdominal vein, and abdominal interstitial fluid and concentration in artery and abdominal vein are shown in Fig. 3 tration (Table 2) were greater than measured abdominal venous blood glycerol concentration (P Ͻ 0.001 for both). Glycerol TTR was consistently greater in arterial plasma (8.34% [7.44 -10 .1]) than abdominal venous plasma (2.34% [1.71-2.69]) (P Ͻ 0.001), which was consistently greater than glycerol TTR in abdominal interstitial fluid (1.44% [1.11-1.79]) (P Ͻ 0.001 for all comparisons), indicating flux of glycerol from adipocytes to interstitial fluid to the vascular compartment (Fig. 3) . There was no significant uptake of glycerol tracer across adipose tissue; labeled blood glycerol content was 2.4% (Ϫ3.7 to 5.0) lower in abdominal venous than arterial samples, not statistically significantly different from zero. Triglyceride concentration. Triglyceride concentrations were consistently lower in abdominal venous plasma (731 mol/l [647-1,133]) than arterial plasma (784 mol/l [678 -1,188], P Ͻ 0.001). ATBF. Median abdominal subcutaneous ATBF was 3.07 ml ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 (2.13-4.06). ATBF correlated with ps (for both boundary conditions (R s Ն 0.55, P Ͻ 0.01) (Fig. 4) , and blood flow was lower in obese than lean subjects (e.g., R s with BMI ϭ Ϫ0.625, P Ͻ 0.001). Table 2 . Figs. 2A and B give an example of the parameter estimates from a single dataset. Table 3 shows parameters for lean (BMI Ͻ25 kg/m 2 ) and obese (BMI Ͼ30 kg/m 2 ) subjects. Boundary condition P. The proportion of arterial glycerol that entered the interstitial space, F ia /F in , was 60.1% (47.8 -81.0) in boundary condition P. This proportion also represents the single-pass unidirectional extraction value. The boundary condition P values for capillary diffusion capacity (ps) and interstitial glycerol concentration are shown in Table 2 . Neither ps nor interstitial glycerol concentration was significantly different between male and female subjects. Age was related to ps (R s ϭ 0.43, P Ͻ 0.05) but not to interstitial glycerol concentration. There was an inverse relationship between ps value and adiposity (correlation ps with BMI R s ϭ Ϫ0.49, ps with percentage IBW R s ϭ Ϫ0. 45 , ps with percent body fat R s ϭ Ϫ0.54, P Ͻ 0.05 for all). There were positive correlations between interstitial glycerol concentration and adiposity (correlation with BMI R s ϭ 0.50, with percentage IBW R s ϭ 0.52, with percent body fat R s ϭ 0.52, P Ͻ 0.05 for all). Boundary condition Q. In boundary condition Q, by Data are median (interquartile range). The local glycerol production rate calculated by assuming the individual ps values were identical to that using arteriovenous balance, but when a ps of 5 was assumed, the production rate increased significantly (P Ͻ 0.001).
Glycerol release rates. Systemic glycerol
definition, all glycerol released by LPL action entered the venous blood without traversing the interstitial space.
Each of the glycerol model parameters, F IA , F VA , and F VI , calculated for boundary condition Q were different from the parameters calculated for boundary condition P in all subjects (P Ͻ 0.001 for all model parameters).
The proportion of arterial glycerol that entered the interstitial space, F ia /F in , was 52.8% (40.8 -65.3), which was consistently less than that seen in boundary condition P (P Ͻ 0.001). This proportion also represents the singlepass unidirectional extraction value.
The calculated values for capillary diffusion capacity (ps) and interstitial glycerol concentration in boundary condition Q are shown in Table 2 . Neither ps nor interstitial glycerol concentration was significantly different be- 
FIG. 4. ATBF (in ml ⅐ 100 g adipose tissue
؊1 ⅐ min ؊1 ) and ps (in ml ⅐ 100 g tissue ؊1 ⅐ min ؊1 ) (for boundary condition Q) for 15 lean subjects (ƒ) and 6 obese subjects (F). Blood flow correlated with ps (R s ‫؍‬ 0.59, P < 0.01). Obese subjects have lower blood flow and ps than lean subjects (P < 0.05 for both).
tween male and female subjects. Permeability surface area (ps) was related to age (R s ϭ 0.42, P Ͻ 0.05), but interstitial glycerol concentration was not. There was significance between ps value and adiposity (correlation with BMI R s ϭ Ϫ0.58, with percentage IBW R s ϭ Ϫ0.49, with percent body fat R s ϭ Ϫ0.68, P Ͻ 0.05 for all). There were positive correlations between interstitial glycerol concentration and adiposity (correlation with BMI R s ϭ 0.41, with percentage IBW R s ϭ 0.41, with percent body fat R s ϭ 0.52, P Ͻ 0.05 for all).
DISCUSSION
In the present study, we adopted a novel approach to study postabsorptive regional abdominal subcutaneous adipose tissue glycerol kinetics in human subjects. Our data demonstrate that glycerol released from subcutaneous adipocytes travels along a concentration gradient from adipose tissue interstitial space to local veins before entering the systemic circulation. Of the glycerol appearing in the venous drainage from adipose tissue (median 732 nmol ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 ), 52% (383 nmol ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 ) was derived from lipolysis of adipocyte triglycerides and 14% (99 nmol ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 ) from lipolysis of circulating plasma triglycerides. Between 8 and 11% (58 -82 nmol ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 , for boundary condition P and Q, respectively) of venous glycerol had been functionally shunted directly from arterial to venous blood without uptake into the interstitium. The remainder of glycerol that appeared in adipose tissue venous drainage was comprised of arterial glycerol that passed into the interstitium before reappearing in the local venous circulation.
Our approach also allowed calculation of the ps index of the capillary perfusion capacity for glycerol in subcutaneous abdominal human adipose tissue. Unfortunately, ps is difficult to measure, and other groups have suggested values ranging from 3.0 to 5.0 ml ⅐ 100 g tissue Ϫ1 ⅐ min Ϫ1 (11, (17) (18) (19) 30) , based in vitro methods (21, (31) (32) (33) (34) . Our calculated values for ps were based on measurements made in vivo and were generally lower than ps values assumed in studies (11, 15, (17) (18) (19) 30) . In our study, ps values declined with increasing adiposity, consistent with the histological changes in adipose tissue observed in obese subjects (35, 36) . Our data suggest that studies of regional lipolytic activity that depend on interstitial glycerol concentration measurements should assume different ps values in lean and obese subjects. It is not known whether different adipose tissue beds have different capillary diffusion capacities, although data from a recent study (22) have shown that ps in human muscle changes in response to physiological stimuli. In our study, variation in ps was significantly related to obesity and age rather than sex, but further work would be necessary to examine whether other factors (e.g., insulin resistance or abnormal LPL activity) are more closely linked to variation in ps. In our study, ps was also related to ATBF, which itself is known to be reduced in obesity (17, 18, 27) . It is likely that both ATBF and ps are reduced by structural alterations that occur in adipose tissue with increased adiposity (i.e., increased distance between capillary and adipocyte, and decreased capillary density); however, the association with blood flow does make it difficult to resolve the independent effects on ps of obesity and of low blood flow.
The ps for glycerol is probably related to the ps for other substances within the same tissue, because glycerol appears to diffuse in and out of tissues without any active transport processes. The methods we have used would allow future exploration of the factors that change the capillary diffusion capacity of human adipose tissue. The consequence of assuming an erroneous value for ps on local glycerol release rate is underscored in Table 3 . Assuming a ps value of 5, rather than using the values calculated from our observations, caused an artifactual increase in local glycerol release rate but did not change the comparison between lean and obese subjects.
The validity of our calculations of ps depends upon the limitations and assumptions of our methods. These assumptions include the following. 1) There was no metabolism of glycerol by adipose tissue, 2) a true steady state was achieved in all sampling sites, 3) microdialysate samples were in equilibrium with interstitial glycerol with no isotope effect, 4) samples obtained by microdialysis were representative of adipose tissue interstitial fluid that was drained by the abdominal vein cannula, and 5) LPLinduced clearance of plasma triglycerides produces glycerol in equimolar amounts with little generation of monoor diglycerides (37) . We also assumed that there was no significant glycerol tracer recycling from adipocyte or plasma triglycerides. The possibility of tracer recycling is unlikely because the adipocyte triglyceride pool is very large, and any labeled glycerol that found its way there would be infinitely diluted. Moreover, there was little incorporation of labeled glycerol into plasma triglyceride during the course of this study.
In the present study, there was no significant glycerol uptake by adipose tissue, which is consistent with previous studies (7, 19) involving labeled glycerol, and the absence of significant glycerol kinase activity in adipose tissue (38) . In contrast, Lee et al. (39) reported acylation of glycerol in several tissues and Kurpad et al. (40) reported significant glycerol-isotope uptake by subcutaneous adipose tissue. However, the Kurpad et al. study may not have achieved steady-state conditions, glycerol balance being assessed after only 60 min of labeled glycerol infusion. In the present study, labeled glycerol was infused for 120 min, and the time-course data ( Fig. 3 and ANOVA) for plasma glycerol concentration and TTR suggest that steady-state conditions were achieved. Although the other assumptions cannot be specifically tested, they have been accepted in previous studies.
Many results seen in this study were similar to previous values. Thus, whole-body glycerol R a was similar to previous reports (5-7), as were arterial and abdominal venous blood glycerol concentrations (7, 11, 12, 27) . The values of calculated interstitial glycerol concentration in the current study are similar to those reported previously and, as expected, show a direct correlation with increasing adiposity (17) (18) . However, our calculated interstitial glycerol concentrations were higher than measured abdominal venous blood glycerol. In contrast, in a previous study (12) that measured interstitial glycerol concentration directly by microdialysis sampling, the value for adipose tissue interstitial glycerol concentration was lower than venous plasma glycerol concentration. The reason for this discrepancy between studies may be related to the technical difficulty in accurately measuring adipose tissue interstitial glycerol concentration directly, which have at times (e.g., Maggs et al. [41] ) yielded results markedly discrepant with other studies (13) and the values we report. Early studies (14 -17) that measured adipose tissue interstitial glycerol concentration by using microdialysis involved a system that had poor glycerol recovery and required time-consuming calibrations. Our calculated values for adipose tissue interstitial glycerol concentration did not require probe calibration or an estimate of probe glycerol recovery. Current probes have Ͼ90% glycerol recovery when the perfusion rate is very slow (42) .
The action of LPL on intravascular circulating triglycerides can release glycerol into the circulation. This study and previous studies (7, 12, 27, 43) show significant clearance of circulating triglyceride by adipose tissue. In this study, the proportion of local glycerol release from LPL action declined significantly with obesity in accordance with previous comparisons of lean and obese subjects (27, 44) .
Some LPL-generated glycerol could diffuse into the interstitium before later release into venous plasma, while another fraction of LPL-generated glycerol would go to the venous blood without traversing the interstitium. Because we did not know the fraction of the LPL glycerol following these two paths, we considered the boundary conditions where 100% of the LPL-generated glycerol goes into the vein directly and none goes into the interstitium (boundary condition Q) or the converse (boundary condition P). The true situation lies between these two extremes, but one can draw inferences from the similarities of the two boundary conditions. LPL action on triglyceride-rich lipoproteins occurs within the capillary lumen (44) so it is plausible that most LPL-generated glycerol is "swept away" directly into the venous blood rather than accessing the interstitial fluid glycerol pool, as argued by Summers et al. (12) . However, some LPL-generated glycerol might be taken up into the interstitial space without mixing with venous blood. Unstirred water layers exist at the boundary of most cell surfaces (45) and such local conditions could theoretically allow LPL-generated glycerol to cross the capillary barrier and enter the interstitial space.
The findings of the present study may not represent glycerol kinetics in other fat depots. In vitro studies of isolated adipocytes demonstrate regional differences in lipolytic activity and hormonal regulation of lipolysis. For example, abdominal adipose tissue is more lipolytic, more sensitive to ␤-adrenergic stimulation, and more resistant to insulin-mediated antilipolysis than gluteal or femoral fat depots (46 -48) . Such heterogeneity of adipose tissue emphasizes that results from a single depot such as the one studied here should be extrapolated to whole-body fat metabolism with caution.
Our results also confirm some limitations of using systemic glycerol R a as a measure of whole-body adipose tissue lipolysis. We found that glycerol released during lipolysis of plasma triglycerides could have accounted for ϳ15-20% of total glycerol added to the bloodstream as it passes through abdominal adipose tissue. In addition, systemic glycerol R a could miss 10 -20% of whole-body adipose tissue lipolysis because of the inability to detect lipolysis of intraperitoneal fat, when glycerol released into the portal vein is cleared by the liver (49) . Therefore, measuring systemic glycerol R a by infusing a labeled glycerol tracer probably provides a reasonable estimate of whole-body adipose tissue lipolytic activity under postabsorptive conditions that simultaneously overestimates (glycerol released by lipolysis of plasma triglycerides) and underestimates (glycerol released by lipolysis of intraperitoneal triglycerides) selected areas of regional adipose tissue glycerol release.
In summary, the data from this study show that glycerol released during lipolysis of adipose tissue triglycerides moves along a concentration gradient from interstitial space, to local veins, and into the systemic circulation. The calculated capillary diffusion capacity (ps) for glycerol increased with increasing adiposity and was lower than values previously proposed by assessments made in vitro.
